AA250 (Zytiga 250 mg)
Generic Name: abiraterone
Pill imprint AA250 has been identified as Zytiga 250 mg.
Zytiga is used in the treatment of prostate cancer and belongs to the drug class miscellaneous antineoplastics. Not for use in pregnancy. Zytiga 250 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
More about Zytiga (abiraterone)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.